Pulmoner Emboli

Yazarlar

İlker Kaçer

Özet

Pulmoner emboli (PE), pulmoner arter veya dallarının çoğunlukla alt ekstremitelerdeki derin ven trombozundan (DVT) köken alan bir pıhtı nedeniyle tıkanması sonucu gelişen acil ve ciddi bir kardiyovasküler hastalıktır. Virchow üçlüsü çerçevesinde venöz staz, hiperkoagülasyon ve endotelyal hasar hastalığın temel etyolojik mekanizmalarını oluşturur. Genetik trombofililerin yanı sıra uzun süreli immobilizasyon, geçirilmiş cerrahi, obezite, gebelik, malignite ve enfeksiyon gibi edinilmiş faktörler PE gelişiminde önemli risk unsurlarıdır. Klinik olarak PE, hipotansiyona ve obstrüktif şoka yol açan hemodinamik olarak unstabil (yüksek riskli) ve hemodinamik olarak stabil olmak üzere sınıflandırılır. Hastalarda en sık görülen semptomlar akut dispne, plöritik göğüs ağrısı, öksürük, hemoptizi ve senkoptur; fizik muayenede ise taşipne ve taşikardi öne çıkar. Değerlendirme sürecinde Wells ve Geneva tahmin skorlamaları ile D-dimer testi klinik olasılığı belirlemede kritik rol oynar. Kesin tanıda çok kesitli bilgisayarlı tomografik pulmoner anjiyografi (CTPA) ilk seçenek görüntüleme yöntemidir; kontrendikasyon mevcudiyetinde ise akciğer V/Q sintigrafisinden yararlanılır. Tedavinin ana bileşenini parenteral veya oral antikoagülasyon (LMWH, UFH, NOAC) oluştururken, hemodinamik dengesizliği olan yüksek riskli olgularda trombolitik tedavi, kateter bazlı embolektomi veya cerrahi müdahale gibi birincil reperfüzyon stratejileri uygulanır. Erken dönem ve 30 günlük mortalite risk takibi ise Pulmoner Emboli Şiddet İndeksi (PESI veya basitleştirilmiş sPESI) skorları ile gerçekleştirilir.

Referanslar

Rini BI, Wilding G, Hudes G, et al.: Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. Journal of Clinical Oncology 27:4462-8, 2009

Rogers MA, Levine DA, Blumberg N, et al.: Triggers of hospitalization for venous thromboembolism. Circulation 125:2092-9, 2012

Blom JW, Doggen CJ, Osanto S, et al.: Malignancies, prothrombotic mutations, and the risk of venous thrombosis. Jama 293:715-22, 2005

Clayton TC, Gaskin M, Meade TW: Recent respiratory infection and risk of venous thromboembolism: case–control study through a general practice database. International journal of epidemiology 40:819-27, 2011

Prandoni P, Pesavento R, Sørensen HT, et al.: Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey. European journal of internal medicine 20:470-3, 2009

Toft H, Horvath-Puho E, Pedersen L, et al.: Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. The Lancet 370:1773-9, 2007

Wendelboe AM, Raskob GE: Global burden of thrombosis: epidemiologic aspects. Circulation research 118:1340-7, 2016

Raskob GE, Angchaisuksiri P, Blanco AN, et al.: Thrombosis: a major contributor to global disease burden. Arteriosclerosis, thrombosis, and vascular biology 34:2363-71, 2014

Horlander KT, Mannino DM, Leeper KV: Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Archives of internal medicine 163:1711-7, 2003

Moser KM: Venous Thrornboembollsm'. Am Rev Respir Dis 141:235-49, 1990

Nakos G, Kitsiouli EI, Lekka ME: Bronchoalveolar lavage alterations in pulmonary embolism. American journal of respiratory and critical care medicine 158:1504-10, 1998

Morrone D, Morrone V: Acute pulmonary embolism: focus on the clinical picture. Korean circulation journal 48:365, 2018

Stein PD, Henry JW: Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest 112:974-9, 1997

Stein PD, Beemath A, Matta F, et al.: Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. The American journal of medicine 120:871-9, 2007

Barco S, Ende-Verhaar YM, Becattini C, et al.: Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis. European heart journal 39:4186-95, 2018

Courtney DM, Sasser HC, Pincus CL, et al.: Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients. Resuscitation 49:265-72, 2001

Kucher N, Goldhaber SZ: Management of massive pulmonary embolism. Circulation 112:e28-e32, 2005

Kiely DG, Kennedy NS, Pirzada O, et al.: Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respiratory medicine 99:1286-91, 2005

Henzler T, Roeger S, Meyer M, et al.: Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. European Respiratory Journal 39:919-26, 2012

Meyer T, Binder L, Hruska N, et al.: Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. Journal of the American College of Cardiology 36:1632-6, 2000

Konstantinides S, Geibel A, Olschewski M, et al.: Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106:1263-8, 2002

Horlander KT, Leeper KV: Troponin levels as a guide to treatment of pulmonary embolism. Current opinion in pulmonary medicine 9:374-7, 2003

Rodger M, Makropoulos D, Turek M, et al.: Diagnostic value of the electrocardiogram in suspected pulmonary embolism. American Journal of Cardiology 86:807-9, 2000

Worsley DF, Alavi A, Aronchick J, et al.: Chest radiographic findings in patients with acute pulmonary embolism: observations from the PIOPED Study. Radiology 189:133-6, 1993

Ghaye B, Szapiro D, Mastora I, et al.: Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology 219:629-36, 2001

Stein PD, Fowler SE, Goodman LR, et al.: Multidetector computed tomography for acute pulmonary embolism. New England Journal of Medicine 354:2317-27, 2006

Reid JH, Coche EE, Inoue T, et al.: Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT. European journal of nuclear medicine and molecular imaging 36:505-21, 2009

Investigators P: Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). Jama 263:2753-9, 1990

Wittram C, Waltman AC, Shepard J-AO, et al.: Discordance between CT and angiography in the PIOPED II study. Radiology 244:883-9, 2007

Stein P, Chenevert T, Fowler S, et al.: PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Investigators. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 152:434-43, 2010

Kearon C, Ginsberg JS, Hirsh J: The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Annals of internal medicine 129:1044-9, 1998

Le Gal G, Righini M, Sanchez O, et al.: A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. THROMBOSIS AND HAEMOSTASIS-STUTTGART- 95:963, 2006

Kline J, Mitchell A, Kabrhel C, et al.: Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. Journal of Thrombosis and Haemostasis 2:1247-55, 2004

Coutance G, Cauderlier E, Ehtisham J, et al.: The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Critical care 15:R103, 2011

Hugli O, Righini M, Le Gal G, et al.: The pulmonary embolism rule‐out criteria (PERC) rule does not safely exclude pulmonary embolism. Journal of thrombosis and haemostasis 9:300-4, 2011

Stein PD, Hull RD, Matta F, et al.: Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. The American journal of medicine 122:919-30, 2009

Cossette B, Pelletier M-È, Carrier N, et al.: Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular weight heparin: a cohort study in the context of a quality improvement initiative. Annals of Pharmacotherapy 44:994-1002, 2010

Goldhaber SZ, Come P, Lee R, et al.: Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. The Lancet 341:507-11, 1993

Daniels LB, Parker JA, Patel SR, et al.: Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. The American journal of cardiology 80:184-8, 1997

Tafur AJ, Shamoun FE, Patel SI, et al.: Catheter-directed treatment of pulmonary embolism: a systematic review and meta-analysis of modern literature. Clinical and Applied Thrombosis/Hemostasis 23:821-9, 2017

Pasrija C, Kronfli A, Rouse M, et al.: Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience. The Journal of thoracic and cardiovascular surgery 155:1095-106. e2, 2018

Boutitie F, Pinede L, Schulman S, et al.: Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials. Bmj 342, 2011

Aujesky D, Obrosky DS, Stone RA, et al.: Derivation and validation of a prognostic model for pulmonary embolism. American journal of respiratory and critical care medicine 172:1041-6, 2005

Jiménez D, Aujesky D, Moores L, et al.: Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Archives of internal medicine 170:1383-9, 2010

Sayfalar

97-114

Gelecek

29 Ekim 2021

Lisans

Lisans